Prostate News and Research

RSS

COVID-19 associated with higher risk of erectile dysfunction

Men previously diagnosed with COVID-19 are at a greater risk of developing new-onset erectile dysfunction.

31 May 2024

Study links low oxytocin levels to symptoms of polycystic ovary syndrome

The role of oxytocin (OT) in polycystic ovary syndrome (PCOS).

29 May 2024

MUSC researchers unravel the mystery of cancer recurrence

MUSC Hollings Cancer Center researchers have unlocked a discovery that could help to explain why cancer can recur in patients who have undergone chemotherapy or radiotherapy.

28 May 2024

Underappreciated set of enzymes connected to the regulation of hippo pathway in cancer

Within the family of cell membrane lipids known as phosphoinositides and the kinase enzymes that regulate them, phosphoinositide 3-kinases (PI3Ks) have been cast in a starring role as scientists study their involvement in cancer, diabetes and many cellular activities.

28 May 2024

Study suggests broccoli may reduce cancer risk

A meta-analysis of over 730,000 individuals indicates that high broccoli consumption is linked to lower cancer prevalence, though more robust research is needed to confirm its chemopreventive properties.

27 May 2024

Study reveals cancer treatment disparities at minority-serving hospitals

It’s important to ensure that care provided at US hospitals that predominantly serve Black and Hispanic populations is as high-quality as the care provided at other US hospitals.

27 May 2024

$Osaka University to pioneer world-first clinical trial for refractory prostate cancer with alpha-ray therapy$

Osaka University to pioneer world-first clinical trial for refractory prostate cancer with alpha-ray therapy

A research team at Osaka University will start an investigator-initiated clinical trial for refractory prostate cancer patients after the successful development of a new alpha-ray therapeutic agent ([At-211] PSMA-5) and confirmation of its efficacy in animal models.

27 May 2024

Physician-pharmacy integration not associated with change in the care of cancer patients

Integration of pharmacies with physician practices, where on-site pharmacies open at physician practice locations, is a growing trend in cancer treatment.

23 May 2024

Determinants of treatment decisions in newly diagnosed prostate cancer patients

Patients with newly diagnosed prostate cancer (PCA) face the critical decision of whether to undergo treatment with curative intent (TCI, surgery or radiation) or conservative treatment on the background of a cancer where the potential for over-treatment and under-treatment is real.

23 May 2024

Study suggests miR-377 as potential therapeutic target for prostate cancer

A new research paper was published in Genes & Cancer on May 16, 2024, entitled, "Inhibitory effect of miR-377 on the proliferative and invasive behaviors of prostate cancer cells through the modulation of MYC mRNA via its interaction with BCL-2/Bax, PTEN, and CDK4."

22 May 2024

Novel therapy reprograms immune cells, shrinks prostate and bladder cancers in animal study

A novel therapy that reprograms immune cells to promote antitumor activity helped shrink hard-to-treat prostate and bladder cancers in mice, according to research from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy and Johns Hopkins Drug Discovery.

21 May 2024

Transformative $8 million donation fuels pancreatic cancer research at WEHI

An exceptional $8 million, 10-year philanthropic investment will spearhead new treatments for pancreatic cancer and create a new dedicated research centre at WEHI.

21 May 2024

Low-fat diets significantly reduce lung cancer risk in older adults, study finds

Study found that adhering to low-fat diets significantly reduces lung cancer risk in older adults, with the most substantial benefits observed in current smokers. High consumption of saturated fats was linked to increased lung cancer risk, particularly for small-cell lung cancer.

20 May 2024

Proteins in the blood could warn people of cancer more than seven years before it is diagnosed

Researchers from the UK investigated associations between 1,463 plasma proteins and 19 cancers, using observational and genetic approaches in participants of the UK Biobank.

17 May 2024

Plant-based diets could reduce the chances of disease progression in men with prostate cancer

Men with prostate cancer could significantly reduce the chances of the disease worsening by eating more fruits, vegetables, nuts, and olive oil, according to new research by UC San Francisco.

13 May 2024

Study reveals latest cancer trends in Canada

The number of cancer cases and deaths in Canada is expected to increase because of a growing and aging population, but the overall rates of people being diagnosed with and dying from cancer will continue to decline, according to the latest cancer trends research in CMAJ.

13 May 2024

DoD grant awarded for investigating alternative polyadenylation in prostate cancer

A team led by Dr. Eddie Imada, assistant professor of research in pathology and laboratory medicine, has been awarded a three-year, $1.5 million United States Department of Defense grant for research on a cellular process called alternative polyadenylation and its role in prostate cancer.

10 May 2024

Precision medicine in PET imaging: AI-based attenuation correction for enhanced patient care

A new research paper was published in Oncotarget's Volume 15 on May 7, 2024, entitled, "Deep learning-based whole-body PSMA PET/CT attenuation correction utilizing Pix-2-Pix GAN."

9 May 2024

Deep learning models for predicting prostate cancer recurrence risk from 3D pathology datasets

Human tissue is intricate, complex and, of course, three dimensional. But the thin slices of tissue that pathologists most often use to diagnose disease are two dimensional, offering only a limited glimpse at the tissue's true complexity.

9 May 2024

Researchers enhance CAR-T cells to target solid tumors

Researchers at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) have shown that a breakthrough therapy for treating blood cancers can be adapted to treat solid tumors-;an advance that could transform cancer treatment.

8 May 2024

Prostate News and Research

COVID-19 associated with higher risk of erectile dysfunction

Study links low oxytocin levels to symptoms of polycystic ovary syndrome

MUSC researchers unravel the mystery of cancer recurrence

Underappreciated set of enzymes connected to the regulation of hippo pathway in cancer

Study suggests broccoli may reduce cancer risk

Study reveals cancer treatment disparities at minority-serving hospitals

Osaka University to pioneer world-first clinical trial for refractory prostate cancer with alpha-ray therapy

Physician-pharmacy integration not associated with change in the care of cancer patients

Determinants of treatment decisions in newly diagnosed prostate cancer patients

Study suggests miR-377 as potential therapeutic target for prostate cancer

Novel therapy reprograms immune cells, shrinks prostate and bladder cancers in animal study

Transformative $8 million donation fuels pancreatic cancer research at WEHI

Low-fat diets significantly reduce lung cancer risk in older adults, study finds

Proteins in the blood could warn people of cancer more than seven years before it is diagnosed

Plant-based diets could reduce the chances of disease progression in men with prostate cancer

Study reveals latest cancer trends in Canada

DoD grant awarded for investigating alternative polyadenylation in prostate cancer

Precision medicine in PET imaging: AI-based attenuation correction for enhanced patient care

Deep learning models for predicting prostate cancer recurrence risk from 3D pathology datasets

Researchers enhance CAR-T cells to target solid tumors

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News